Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Neuropharmacol. 2012 Jun;10(2):159-66. doi: 10.2174/157015912800604515.

Cannabinoid modulation of neuroinflammatory disorders.

Author information

1
Laboratory of Immunopharmacology, Graduate Program in Neurosciences, UFMG, Belo Horizonte, Brazil.

Abstract

In recent years, a growing interest has been dedicated to the study of the endocannabinoid system. The isolation of Cannabis sativa main psychotropic compound, Δ(9)-tetrahydrocannabinol (THC), has led to the discovery of an atypical neurotransmission system that modulates the release of other neurotransmitters and participates in many biological processes, including the cascade of inflammatory responses. In this context, cannabinoids have been studied for their possible therapeutic properties in neuroinflammatory diseases. In this review, historic and biochemical aspects of cannabinoids are discussed, as well as their function as modulators of inflammatory processes and therapeutic perspectives for neurodegenerative disorders, particularly, multiple sclerosis.

KEYWORDS:

Cannabinoid receptors; Cannabinoids; Inflammation; Multiple sclerosis; Nervous system diseases; Parkinson Disease.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center